These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10775040)

  • 21. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS.
    Samara MT; Engel RR; Millier A; Kandenwein J; Toumi M; Leucht S
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1767-72. PubMed ID: 25219937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study.
    Gaite L; Vázquez-Barquero JL; Herrán A; Thornicroft G; Becker T; Sierra-Biddle D; Ruggeri M; Schene A; Knapp M; Vázquez-Bourgon J;
    Compr Psychiatry; 2005; 46(6):440-6. PubMed ID: 16275211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global assessment of psychosocial functioning in child and adolescent psychiatry. A review of three unidimensional scales (CGAS, GAF, GAPD).
    Schorre BE; Vandvik IH
    Eur Child Adolesc Psychiatry; 2004 Oct; 13(5):273-86. PubMed ID: 15490275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA; Luckenbaugh DA; Altshuler LL; Suppes T; McElroy SL; Frye MA; Kupka RW; Keck PE; Leverich GS; Post RM
    Am J Psychiatry; 2004 Aug; 161(8):1447-54. PubMed ID: 15285972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Qualitative Study of Clinicians Experience with Rating of the Global Assessment of Functioning (GAF) Scale.
    Aas IHM; Sonesson O; Torp S
    Community Ment Health J; 2018 Jan; 54(1):107-116. PubMed ID: 27904986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimensional representations of DSM-IV personality disorders: relationships to functional impairment.
    Skodol AE; Oldham JM; Bender DS; Dyck IR; Stout RL; Morey LC; Shea MT; Zanarini MC; Sanislow CA; Grilo CM; McGlashan TH; Gunderson JG
    Am J Psychiatry; 2005 Oct; 162(10):1919-25. PubMed ID: 16199839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axis V - Global Assessment of Functioning scale (GAF), further evaluation of the self-report version.
    Ramirez A; Ekselius L; Ramklint M
    Eur Psychiatry; 2008 Dec; 23(8):575-9. PubMed ID: 18774271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global assessment of functioning. A modified scale.
    Hall RC
    Psychosomatics; 1995; 36(3):267-75. PubMed ID: 7638314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the global assessment of functioning: learning from Virginia Apgar.
    Dimsdale JE; Jeste DV; Patterson TL
    Psychosomatics; 2010; 51(6):515-9. PubMed ID: 21051684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability and validity of the Global Assessment of Functioning Scale in clinical outpatients with depressive disorders.
    Grootenboer EM; Giltay EJ; van der Lem R; van Veen T; van der Wee NJ; Zitman FG
    J Eval Clin Pract; 2012 Apr; 18(2):502-7. PubMed ID: 21223457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.
    Matsunaga M; Okamoto Y; Suzuki S; Kinoshita A; Yoshimura S; Yoshino A; Kunisato Y; Yamawaki S
    BMC Psychiatry; 2010 Mar; 10():22. PubMed ID: 20230649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome.
    Yi JJ; Calkins ME; Tang SX; Kohler CG; McDonald-McGinn DM; Zackai EH; Savitt AP; Bilker WB; Whinna DA; Souders MC; Emanuel BS; Gur RC; Gur RE
    J Clin Psychiatry; 2015 Oct; 76(10):e1262-70. PubMed ID: 26528648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological, social and role functioning as predictors of psychosis in an adolescent psychiatric sample.
    Ärmänen A; Lahti M; Therman S; Suvisaari J; Lindgren M
    Early Interv Psychiatry; 2018 Dec; 12(6):1064-1071. PubMed ID: 28124493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and psychosocial variables in different diagnostic groups: their interrelationships and value as predictors of course and outcome during a 14-year follow-up.
    Vetter P; Köller O
    Psychopathology; 1996; 29(3):159-68. PubMed ID: 8817735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year follow-up of day treatment for poorly functioning patients with personality disorders.
    Wilberg T; Urnes O; Friis S; Irion T; Pedersen G; Karterud S
    Psychiatr Serv; 1999 Oct; 50(10):1326-30. PubMed ID: 10506302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.